Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Telemedicine
DEA Seeking Input on Prescribing Controlled Substances via Telemedicine
The United States Drug Enforcement Administration (DEA) announced that it is seeking public input “concerning the practice of…
HIPAA Enforcement Discretion Ends as Part of COVID Public Health Emergency…
As with many other things, the Notifications of Enforcement Discretion issued during the COVID-19 public health emergency by the…
HHS OIG Releases Telehealth HHS OIG Toolkit
HHS OIG has said that during 2020, the use of telehealth services increased dramatically, with Medicare beneficiaries using 88…
DEA Announces Extension of Telemedicine Flexibilities, Despite PHE Ending
Just one day before the COVID-19 Public Health Emergency was set to expire, the United States Drug Enforcement Administration…
The Impact of Ending the Public Health Emergency on Telemedicine
On January 30, 2023, the White House issued a statement that the Biden Administration will end the COVID-19 public health…
The Pill Club Reaches $18 Million California Settlement Over Fraud…
California Attorney General Rob Bonta recently announced a settlement with The Pill Club, an online women’s pharmacy, over…
Alliance for Connected Care Calls for Telehealth Flexibility Extension
With the COVID-19 public health emergency (PHE) set to expire on May 11, 2023, the Alliance for Connected Care wrote a letter to…
DEA Proposes Making Telemedicine Flexibilities Permanent
The Drug Enforcement Administration (DEA) recently announced making permanent changes to the rules for prescribing controlled…
AMGA Pushes for Continuation of Telehealth Flexibilities
AMGA recently sent a letter to the Congressional Telehealth Caucus, agreeing that updates should be made to the CONNECT Act to…
What Does the Future Hold for Telehealth?
Telehealth remains a major topic of debate and study in the health policy community. This article looks at several recent…